Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,826 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2.
Vera O, Bok I, Jasani N, Nakamura K, Xu X, Mecozzi N, Angarita A, Wang K, Tsai KY, Karreth FA. Vera O, et al. Among authors: nakamura k. Cancers (Basel). 2021 Mar 19;13(6):1408. doi: 10.3390/cancers13061408. Cancers (Basel). 2021. PMID: 33808771 Free PMC article.
A Versatile ES Cell-Based Melanoma Mouse Modeling Platform.
Bok I, Vera O, Xu X, Jasani N, Nakamura K, Reff J, Nenci A, Gonzalez JG, Karreth FA. Bok I, et al. Among authors: nakamura k. Cancer Res. 2020 Feb 15;80(4):912-921. doi: 10.1158/0008-5472.CAN-19-2924. Epub 2019 Nov 19. Cancer Res. 2020. PMID: 31744817 Free PMC article.
Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A, Sawada K, Nakamura K, Kinose Y, Nakatsuka E, Kobayashi M, Miyamoto M, Ishida K, Matsumoto Y, Kodama M, Hashimoto K, Mabuchi S, Kimura T. Yoshimura A, et al. Among authors: nakamura k. BMC Cancer. 2018 Nov 5;18(1):1065. doi: 10.1186/s12885-018-4974-5. BMC Cancer. 2018. PMID: 30396333 Free PMC article.
Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
Kobayashi M, Sawada K, Nakamura K, Yoshimura A, Miyamoto M, Shimizu A, Ishida K, Nakatsuka E, Kodama M, Hashimoto K, Mabuchi S, Kimura T. Kobayashi M, et al. Among authors: nakamura k. J Ovarian Res. 2018 Sep 15;11(1):81. doi: 10.1186/s13048-018-0458-0. J Ovarian Res. 2018. PMID: 30219071 Free PMC article.
Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer.
Kobayashi M, Sawada K, Miyamoto M, Shimizu A, Yamamoto M, Kinose Y, Nakamura K, Kawano M, Kodama M, Hashimoto K, Kimura T. Kobayashi M, et al. Among authors: nakamura k. Biochem Biophys Res Commun. 2020 Jun 18;527(1):153-161. doi: 10.1016/j.bbrc.2020.04.076. Epub 2020 Apr 28. Biochem Biophys Res Commun. 2020. PMID: 32446360
14,826 results
You have reached the last available page of results. Please see the User Guide for more information.